✦ LIBER ✦

Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients

✍ Scribed by T. Fairhead; E. Hendren; K. Tinckam; C. Rose; C.H. Sherlock; L. Shi; N.S. Crowcroft; J.B. Gubbay; D. Landsberg; G. Knoll; J. Gill; D. Kumar

Book ID: 117968370
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 105 KB
Volume: 14
Category: Article
ISSN: 1398-2273
DOI: 10.1111/tid.12006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Seroprotective Titers against 2009 H1N1

Seroprotective Titers against 2009 H1N1 Influenza A Virus after Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

✍ Nicolas C. Issa; Francisco M. Marty; Lisa S. Gagne; Sophia Koo; Kelly A. Verrill 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Early post-transplant vaccination with p

Early post-transplant vaccination with pandemic influenza A/H1N1 vaccine in pediatric heart transplant recipients

✍ Luis Altamirano-Diaz; Lori West; Atul Humar; Leticia Ely; Simon Urschel; Jonatha 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

De Novo Anti-HLA Antibody After Pandemic

De Novo Anti-HLA Antibody After Pandemic H1N1 and Seasonal Influenza Immunization in Kidney Transplant Recipients

✍ I. Katerinis; K. Hadaya; R. Duquesnoy; S. Ferrari-Lacraz; S. Meier; C. van Delde 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Prolonged shedding of pandemic influenza

Prolonged shedding of pandemic influenza A (H1N1) 2009 virus in a pancreas-after-kidney transplant recipient

✍ Bruminhent, Jackrapong; Deziel, Paul J.; Wotton, Jason T.; Binnicker, Matthew J. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Immune response to pandemic H1N1 2009 in

Immune response to pandemic H1N1 2009 influenza a vaccination in pediatric liver transplant recipients

✍ Wolfram Haller; Jim Buttery; Karen Laurie; Kathe Beyerle; Winita Hardikar; Georg 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB

After the announcement of a worldwide pandemic in June 2009, a single dose of a monovalent pandemic H1N1 2009 influenza A (pH1N1/09) vaccine was advocated for all Australians who were 10 years and older because of excellent immunogenicity trial results for healthy children and adults. Immunocompromi

Pandemic influenza A H1N1 vaccine in rec

Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: Immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination

✍ Heimo Lagler; Judith M. Wenisch; Selma Tobudic; Guido A. Gualdoni; Susanne Rödle 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 302 KB